FDA Inspection 1288668 — Andrew A. Klein, MD
The FDA completed an inspection of Andrew A. Klein, MD on September 11, 2025 in Cambridge. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 11, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Cambridge (United Kingdom)
Additional Details
Clinical Investigator (CI)